The ScholarGPS website collects information through the use of "cookies" or similar technologies in order to function more efficiently and analyze use of the website. You are free to restrict or block cookies as further explained in our Cookies Policy, however depending on the selection of your settings, the full features/functionality of the website may no longer be available.

Decline

Deferoxamine

Deferoxamine (DFOA), also known as desferrioxamine and sold under the brand name Desferal, is a medication that binds iron and aluminium. It is used by injection into a muscle, vein, or under the skin.

 More from Wikipedia

Metrics Summary

Total Publications

Lifetime

3,309

Prior Five Years

310

Total Citations

Lifetime

65,804

Prior Five Years

2,819

Total Scholars

Lifetime

7,060

Prior Five Years

4,689

Institutional Rankings

Global (Worldwide)

Academic Institutions Lifetime		Academic Institutions Prior Five Years		Non-academic Institutions Lifetime
#1	University of Michigan United States	#1	University of Sydney Australia	#1	Beth Israel Deaconess Medical Center United States
#2	Hebrew University of Jerusalem Israel	#2	Stanford University United States	#2	Royal Free Hospital
#3	University College London United Kingdom	#3	University of São Paulo Brazil	#3	United States Department of Health and Human Services United States
#4	King's College London United Kingdom			#4	UCSF Benioff Children’s Hospital Oakland United States
#5	University of Essex United Kingdom
#6	National University of Singapore Singapore
#7	Imperial College London United Kingdom
#8	University of Ferrara Italy
#9	University of Toronto Canada
#10	Columbia University United States
	Show More

National Institutional Rankings

Publications and Citation History

Publications based on Disciplines

Scholars based on Disciplines

Publications based on Fields

Scholars based on Fields

Highly Ranked Scholars™

Lifetime

Prior Five Years

Evaluation Period:

Highly Cited Publications

Lifetime